Lisata Therapeutics Inc expected to post a loss of 89 cents a share - Earnings Preview

Lisata Therapeutics

27/02/2024 21:25

* Lisata Therapeutics Inc  LSTA.OQ   LSTA.O  is expected
to show
no change in quarterly revenue when it reports  results on
February 29 for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Lisata Therapeutics Inc
is for
a loss of 89 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lisata
Therapeutics Inc is $15.50​, above​ its last closing price
of $3.02. ​​​

This summary was machine generated February 27 at 21:25 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)